Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-014545

Chief Executive Officer sold 19,045 shares at $103.69 ($1,974,738)

  • Chief Executive Officer acquired 36,413 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Sale : show line 1 in the form −19,045 $103.69 $1,974,738 634,493 D
2026-11-16 Grant or award : show line 2 in the form +36,413 670,906 D
Open-market sales · 19,045 sh · avg $103.69 · $1,974,738
Loading xslF345X06/marketforms-74343.xml…